For Theranos founder Elizabeth Holmes, taking the stand in her fraud trial would offer a chance to reclaim the narrative of her rise and fall and provide context for her decisions as CEO. But that may not outweigh the risk.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
